Document is current
Any future updates will be listed below
-
Authors
Miller, Andrew H. https://orcid.org/0000-0001-8260-7997
Raison, Charles L. https://orcid.org/0000-0001-6687-0066
- License Information
-
More Information
Article History
Received: 25 April 2023
Revised: 13 May 2023
Accepted: 13 June 2023
First Online: 23 June 2023
Competing interests
: AHM is a paid consultant for Cerevel Therapeutics and Sirtsei Pharmaceuticals, Inc., and CLR is a paid consultant for Novartis, Alfasigma USA Inc., Usona Institute, and Emory Healthcare.
